Abstract
Poorly differentiated thyroid carcinomas are diagnostically controversial, as there is a lack of consensus regarding diagnostic criteria. Poorly differentiated thyroid carcinomas usually occur in older patients (>50 years) and are more common in Italy and Latin America (4–7 % of thyroid carcinomas) and less common in the United States. These tumors are morphologically and prognostically intermediate between well-differentiated and anaplastic thyroid carcinoma. An operational pathologic definition offered in 2007 included insular and trabecular variants, but not solid lesions or more differentiated tumors that may have a poor prognosis, such as tall cell, columnar, diffuse sclerosing, and oncocytic lesions. At a consensus conference in Turin in 2006, 12 thyroid pathologists evaluated 83 tumors without knowledge of clinical parameters and devised a diagnostic algorithm for the diagnosis of poorly differentiated thyroid carcinoma to include “(1) presence of a solid/trabecular/insular pattern of growth, (2) absence of the conventional nuclear features of papillary carcinoma, and (3) presence of at least one of the following features: convoluted nuclei; mitotic activity ≥3×10 HPF [high-power fields]; and tumor necrosis.”
Access provided by Autonomous University of Puebla. Download chapter PDF
Keywords
- Anaplastic Thyroid Carcinoma
- Poor Differentiation
- Conventional Nuclear Features
- Oncocytic Lesions
- Trabecular Variant
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Poorly differentiated thyroid carcinomas are diagnostically controversial, as there is a lack of consensus regarding diagnostic criteria [1–3]. Poorly differentiated thyroid carcinomas usually occur in older patients (>50 years) and are more common in Italy and Latin America (4–7 % of thyroid carcinomas) and less common in the United States [4]. These tumors are morphologically and prognostically intermediate between well-differentiated and anaplastic thyroid carcinoma [2, 5]. An operational pathologic definition offered in 2007 included insular and trabecular variants, but not solid lesions or more differentiated tumors that may have a poor prognosis, such as tall cell, columnar, diffuse sclerosing, and oncocytic lesions [2]. At a consensus conference in Turin in 2006, 12 thyroid pathologists evaluated 83 tumors without knowledge of clinical parameters and devised a diagnostic algorithm for the diagnosis of poorly differentiated thyroid carcinoma to include “(1) presence of a solid/trabecular/insular pattern of growth, (2) absence of the conventional nuclear features of papillary carcinoma, and (3) presence of at least one of the following features: convoluted nuclei; mitotic activity ≥3 × 10 HPF [high-power fields]; and tumor necrosis” [5]. A subsequent study of 56 cases from the Mayo Clinic and 96 from the University of Turin in northern Italy validated the Turin criteria [6]. The prevalence of poorly differentiated carcinoma in the United States was 1.8 and 6.7 % in the northern Italy cases. Tumor characteristics were similar, except extensive vascular invasion and prevalent insular growth was less common in the US cases than the Italian cases [6]. The Turin criteria work well for cases from mountain areas such as northern Italy, where most thyroid carcinomas with high-grade features also have a solid/trabecular/insular growth pattern [3]. However, this algorithm may not work as well for cases from other geographic areas that may have tumors with more heterogeneous architectural and cytologic features, and some pathologists base their diagnosis on only high-grade features, mitotic index, and necrosis, irrespective of the growth pattern [3]. Tumor necrosis and high mitotic activity, rather than growth pattern or histologic subtype, may be prognostic in thyroid tumors [1]. Poorly differentiated tumors have lower relapse-free and cause-specific survival rates than well-differentiated tumors, and poor differentiation and age affect survival [7]. Extrathyroidal infiltration also affects disease-free survival [7]. Aggressive surgery for tumors with gross extrathyroidal extension has resulted in satisfactory locoregional control [8]. Although the benefit of iodine-131 is unclear, it has been recommended for all patients postoperatively because of its lack of morbidity and potential for benefit [2]. External-beam radiotherapy has been suggested for T3 tumors without distant metastasis, all T4 tumors, and all tumors with regional node metastases [2]. The 5-year overall survival rate for poorly differentiated thyroid carcinoma is 47 % [8].
References
Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol. 2011;22(4):190–4.
Sanders Jr EM, et al. An evidence-based review of poorly differentiated thyroid cancer. World J Surg. 2007;31(5):934–45.
Volante M, Papotti M. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol. 2010;21(1):1–6.
DeLellis RA, Lloyd RV, Heitz PU. WHO classification of tumours—pathology and genetics. In: DeLellis RA, Lloyd RV, Heitz PU, editors. Tumours of endocrine organs. Lyon: IARC Press; 2004.
Volante M, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256–64.
Asioli S, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23(9):1269–78.
Tanaka K, et al. Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma. ISRN Endocrinol. 2011;2011:308029.
Ibrahimpasic T, et al. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986–2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid. 2013;23(8):997–1002.
Papotti M, et al. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol. 1993;17(3):291–301.
Volante M, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100(5):950–7.
Nikiforov YE. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol. 2004;15(4):319–27.
Albores-Saavedra J, Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol. 2004;15(4):297–305.
Volante M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab. 2009;94(12):4735–41.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this chapter
Cite this chapter
Erickson, L.A. (2014). Poorly Differentiated Thyroid Carcinoma. In: Atlas of Endocrine Pathology. Atlas of Anatomic Pathology. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0443-3_9
Download citation
DOI: https://doi.org/10.1007/978-1-4939-0443-3_9
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-0442-6
Online ISBN: 978-1-4939-0443-3
eBook Packages: MedicineMedicine (R0)